News

Novo Nordisk has launched Wegovy in India, a weight-loss drug challenging Eli Lilly's Mounjaro. Available by June 2025, ...
We wanted to price it in India in a way which is comparable to the therapies that are available,' said Vikrant Shrotriya, ...
Danish pharma giant Novo Nordisk’s announcement comes months after the launch of another top selling obesity drug Mounjaro in India by US based pharma giant Eli Lilly & Company.
The achievement of that goal in India, which ranks third in obesity numbers after the US and China, will shatter the record ...
Novo Nordisk has launched Wegovy, a weight loss injection, in India, challenging Eli Lilly's Mounjaro. Available by June 2025 ...
India's anti-obesity drug market is currently valued at Rs 3,000-3,500 crore & is projected to grow nearly eightfold by 2030, according to market estimates.
Wegovy 2.4mg is administered through a once-weekly FlexTouch pen, and is suitable for adults with obesity (BMI ≥30 kg/m²), or overweight (BMI ≥27 to <30 kg/m²) with at least one weight-related ...
Factor Zepbound for weight loss and weight management Wegovy for weight loss and weight management; Form: liquid solution in two forms, each for injection under your skin: • single-use pen ...